title: In vivo effects of adenosine 5'-triphosphate on rat preneoplastic liver.
abstract: The utilization of adenosine 5'-triphosphate (ATP) infusions to inhibit the growth of some human and animals tumors was based on the anticancer activity observed in in vitro and in vivo experiments, but contradictory results make the use of ATP in clinical practice rather controversial. Moreover, there is no literature regarding the use of ATP infusions to treat hepatocarcinomas. The purpose of this study was to investigate whether ATP prevents in vivo oncogenesis in very-early-stage cancer cells in a well characterized two-stage model of hepatocarcinogenesis in the rat. As we could not preclude the possible effect due to the intrinsic properties of adenosine, a known tumorigenic product of ATP hydrolysis, the effect of the administration of adenosine was also studied. Animals were divided in groups: rats submitted to the two stage preneoplasia initiation/promotion model of hepatocarcinogenesis, rats treated with intraperitoneal ATP or adenosine during the two phases of the model and appropriate control groups. The number and volume of preneoplastic foci per liver identified by the expression of glutathione S-transferase placental type and the number of proliferating nuclear antigen positive cells significantly increased in ATP and adenosine treated groups. Taken together, these results indicate that in this preneoplastic liver model, ATP as well as adenosine disturb the balance between apoptosis and proliferation contributing to malignant transformation.
authors.affiliation: Instituto Universitario Italiano de Rosario, Rosario.
authors.forename: Ana V
authors.initials: AV
authors.lastname: Frontini
authors.forename: Carlos D
authors.initials: CD
authors.lastname: De La Vega Elena
authors.forename: María V
authors.initials: MV
authors.lastname: Nicolorich
authors.forename: Ariel
authors.initials: A
authors.lastname: Naves
authors.forename: Pablo
authors.initials: P
authors.lastname: Schwarzbaum
authors.forename: Graciela D
authors.initials: GD
authors.lastname: Venera
mesh_terms: D000255:Adenosine Triphosphate / Q000627:therapeutic use*; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D049109:Cell Proliferation / Q000187:drug effects; D004353:Drug Evaluation, Preclinical; D005982:Glutathione Transferase / Q000032:analysis; D008099:Liver / Q000187:drug effects / Q000201:enzymology; D008114:Liver Neoplasms, Experimental / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D011230:Precancerous Conditions / Q000188:drug therapy* / Q000473:pathology*; D011817:Rabbits; D051381:Rats; D017208:Rats, Wistar
chemical_list: D000970:Antineoplastic Agents; D000255:Adenosine Triphosphate; D005982:Glutathione Transferase